Global Healthcare Business and Technology Expert Leads Company Growth in Chronic Liver Disease Assessment

PARIS–(BUSINESS WIRE)–Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, announces the appointment of Dominique Legros as Group CEO, based at the corporate headquarters and offices in Paris, France. A senior-level business executive with diverse, international experience in both small companies and large global corporations, including Johnson & Johnson, Dentsply and Dentsply Sirona, Legros brings cultural sensitivity and significant expertise in successfully developing, transforming and leading enterprises worldwide, spanning France, Switzerland, Germany and the United States.

 “To drive the growth of Echosens in the coming years, Dominique will draw upon his depth of strategic global business experience coupled with a passion for product innovation that results in competitive market positioning,” says Laurent Sandrin, chairman and co-founder of Echosens. “We are fortunate to attract a leader with such an impressive track record for identifying and leveraging organic growth opportunities, as well as the ability to optimize talent, improve business operations and lead change across business operations.”

Legros has held several high-level positions in research and development, sales, marketing and general management across various industries, including medical device, dental equipment and consumables, power generation, oil and gas and aerospace.

In 2011, he joined Dentsply, the leading company in the world dental market, and later led Dentsply Sirona, its global endodontics business based in Switzerland. In 2017, he was named senior vice president in charge of the Technology & Equipment businesses based in Germany, a sector that includes equipment used in dental offices and laboratories, such as imaging, CAD/CAM and dental chairs.

Prior to this, he held leadership positions at Johnson & Johnson in the areas of neurosurgery, orthopedics and for the sterilization and disinfection equipment business.

Legros concludes, “I look forward to working with the exceptional team at Echosens and to further expanding its impressive global footprint. Echosens will bring the benefits of its full range of products and services to an even greater number of physicians throughout the world and support their assessment and management of patients with chronic liver disease.”

Legros holds an MS degree from the Arts & Métiers ParisTech University.